Concepedia

Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders

Christian P. Schaaf, Aniko Sabo, Yasunari Sakai, Jeffrey R. Crosby, Donna M. Muzny, Alicia Hawes, Lora Lewis, Haji Akbar, R. Varghese, Eric Boerwinkle,

Human Molecular Genetics · 2011 · 182 citations · 35 references

DOI Full text

Open access

Concepts

Life SciencesGeneticsMolecular GeneticsAutism Spectrum DisordersMedical GeneticsNeurogeneticsAutism Spectrum Disorder GeneticsCopy Number VariantsGenetic DisordersMolecular NeurogeneticsNeurodevelopmental DisordersNeurodevelopmental GeneticsAutism Spectrum Disorder Copy Number VariantsCopy Number Variations In Developmental DisordersDe Novo Mutations In Developmental DisordersIdiopathic EtiologyNeurodevelopmental Copy Number VariantsNeurodevelopmental Disorder MutationsSyndromic Autism Spectrum Disorder

TL;DR

Autism spectrum disorders are heterogeneous neuro‑developmental disorders, and while genes and copy number variants have been identified for syndromic autism, the etiology of idiopathic non‑syndromic autism remains largely unknown. In 339 high‑functioning idiopathic ASD probands, Sanger sequencing of 21 known autism genes revealed de novo mutations in 1.8% and oligogenic heterozygosity in 6.8%, a rate significantly higher than in controls, suggesting oligogenic heterozygosity as a potential pathogenic mechanism.

Abstract

Autism spectrum disorders (ASDs) are a heterogeneous group of neuro-developmental disorders. While significant progress has been made in the identification of genes and copy number variants associated with syndromic autism, little is known to date about the etiology of idiopathic non-syndromic autism. Sanger sequencing of 21 known autism susceptibility genes in 339 individuals with high-functioning, idiopathic ASD revealed de novo mutations in at least one of these genes in 6 of 339 probands (1.8%). Additionally, multiple events of oligogenic heterozygosity were seen, affecting 23 of 339 probands (6.8%). Screening of a control population for novel coding variants in CACNA1C, CDKL5, HOXA1, SHANK3, TSC1, TSC2 and UBE3A by the same sequencing technology revealed that controls were carriers of oligogenic heterozygous events at significantly (P < 0.01) lower rate, suggesting oligogenic heterozygosity as a new potential mechanism in the pathogenesis of ASDs.